Stock Scorer

Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. reported revenue of 239K USD for the quarter ending 30 June 2026, down 53.9% from 518K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 239K -53.9%
Gross Profit Q2 '26 · ending 30 June 2026 157K -53.6%
Operating Income Q2 '26 · ending 30 June 2026 -11.4M —
Net Income Q2 '26 · ending 30 June 2026 -11.3M —
Cost of Revenue Q2 '26 · ending 30 June 2026 82K -54.4%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -9.3M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -10M —
Shares Outstanding Q2 '26 · ending 30 June 2026 36.8M +43.0%
EPS Q2 '26 · ending 30 June 2026 -1.51 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 4.1M-51.1M-50.2M-25.4M
20242024-12-31 1.9M-61M-60.7M-21.2M
20232023-12-31 1.5M-25.1M-27.8M-23.6M
20222022-12-31 958K-18M-72.9M-49.9M
20212021-12-31 2.2M-53.7M-64.1M-38.2M
20202020-12-31 1.2M-29.7M-29.9M-27.2M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30239K
Q1 '262026-03-3132K
Q4 '252025-12-311.1M
Q3 '252025-09-30260K
Q2 '252025-06-30518K
Q1 '252025-03-312.1M
Q4 '242024-12-311.5M
Q3 '242024-09-30115K
Q2 '242024-06-30104K
Q1 '242024-03-31176K
Q4 '232023-12-31314K
Q3 '232023-09-30429K
Q2 '232023-06-30463K
Q1 '232023-03-31297K
Q4 '222022-12-31274K
Q3 '222022-09-3067K
Q2 '222022-06-30237K
Q1 '222022-03-31380K
Q4 '212021-12-313.6M
Q3 '212021-09-30984K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-30157K
Q1 '262026-03-3115K
Q4 '252025-12-31496K
Q3 '252025-09-30139K
Q2 '252025-06-30338K
Q1 '252025-03-311.3M
Q4 '242024-12-31595K
Q3 '242024-09-3050K
Q2 '242024-06-3050K
Q1 '242024-03-3145K
Q3 '232023-09-30248K
Q2 '232023-06-30272K
Q1 '232023-03-3110K
Q4 '222022-12-31-27K
Q3 '222022-09-30-269K
Q2 '222022-06-3031K
Q1 '222022-03-31247K
Q4 '212021-12-312.6M
Q3 '212021-09-30-866K
Q2 '212021-06-30-394K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-11.4M
Q1 '262026-03-31-4.4M
Q4 '252025-12-31-23.4M
Q3 '252025-09-30-11M
Q2 '252025-06-30-9.8M
Q1 '252025-03-31-6.8M
Q4 '242024-12-31-33.6M
Q3 '242024-09-30-13.5M
Q2 '242024-06-30-4.6M
Q1 '242024-03-31-9.3M
Q4 '232023-12-31-16.2M
Q3 '232023-09-30-6.5M
Q2 '232023-06-30-8.3M
Q1 '232023-03-315.8M
Q4 '222022-12-31-11.6M
Q3 '222022-09-30-1.7M
Q2 '222022-06-30-1.6M
Q1 '222022-03-31-3M
Q4 '212021-12-31-35.7M
Q3 '212021-09-30-13.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-11.3M
Q1 '262026-03-31-4.3M
Q4 '252025-12-31-23M
Q3 '252025-09-30-10.9M
Q2 '252025-06-30-9.7M
Q1 '252025-03-31-6.7M
Q4 '242024-12-31-33.5M
Q3 '242024-09-30-13.5M
Q2 '242024-06-30-4.5M
Q1 '242024-03-31-9.1M
Q4 '232023-12-31-16M
Q3 '232023-09-30-6.5M
Q2 '232023-06-30-8.3M
Q1 '232023-03-313M
Q4 '222022-12-31-45M
Q3 '222022-09-30-9.3M
Q2 '222022-06-30-8.3M
Q1 '222022-03-31-10.3M
Q4 '212021-12-31-35.9M
Q3 '212021-09-30-13.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-3082K
Q1 '262026-03-3117K
Q4 '252025-12-31643K
Q3 '252025-09-30121K
Q2 '252025-06-30180K
Q1 '252025-03-31813K
Q4 '242024-12-31869K
Q3 '242024-09-3043K
Q2 '242024-06-3032K
Q1 '242024-03-31109K
Q4 '232023-12-31409K
Q3 '232023-09-30159K
Q2 '232023-06-30169K
Q1 '232023-03-31265K
Q4 '222022-12-31278K
Q3 '222022-09-30314K
Q2 '222022-06-30183K
Q1 '222022-03-31105K
Q4 '212021-12-312.2M
Q3 '212021-09-30860K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-9.3M
Q1 '262026-03-31-7.6M
Q4 '252025-12-31-5.5M
Q3 '252025-09-30-4.6M
Q2 '252025-06-30-6.2M
Q1 '252025-03-31-5.8M
Q4 '242024-12-31-5.4M
Q3 '242024-09-30-5.5M
Q2 '242024-06-30-6M
Q1 '242024-03-31-3.8M
Q4 '232023-12-31-4.4M
Q3 '232023-09-30-3.8M
Q2 '232023-06-30-6.8M
Q1 '232023-03-31-8.3M
Q4 '222022-12-31-9.6M
Q3 '222022-09-30-11.4M
Q2 '222022-06-30-11.2M
Q1 '222022-03-31-13.3M
Q4 '212021-12-31-7.1M
Q3 '212021-09-30-11M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-10M
Q1 '262026-03-31-8.3M
Q4 '252025-12-31-7M
Q3 '252025-09-30-5.7M
Q2 '252025-06-30-6.5M
Q1 '252025-03-31-6.1M
Q4 '242024-12-31-5.6M
Q3 '242024-09-30-5.6M
Q2 '242024-06-30-6.2M
Q1 '242024-03-31-3.9M
Q4 '232023-12-31-4.7M
Q4 '222022-12-31-10.4M
Q3 '222022-09-30-12.3M
Q2 '222022-06-30-12.4M
Q1 '222022-03-31-14.8M
Q4 '212021-12-31-7.5M
Q3 '212021-09-30-11.4M
Q2 '212021-06-30-8.7M
Q1 '212021-03-31-10.7M
Q4 '202020-12-31-6.3M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3036.8M
Q1 '262026-03-3134.5M
Q3 '252025-09-3032M
Q2 '252025-06-3032M
Q1 '252025-03-3125.7M
Q3 '242024-09-3013.7M
Q2 '242024-06-3012.9M
Q1 '242024-03-318.3M
Q3 '232023-09-308.3M
Q2 '232023-06-308.1M
Q1 '232023-03-316M
Q3 '222022-09-305.9K
Q2 '222022-06-305.7K
Q1 '222022-03-3192.2M
Q3 '212021-09-3091.5M
Q2 '212021-06-3089.8M
Q1 '212021-03-3182.1M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-1.51
Q1 '262026-03-31-1.50
Q4 '252025-12-31-1.64
Q3 '252025-09-30-3.20
Q2 '252025-06-30-3.84
Q1 '252025-03-31-3.90
Q4 '242024-12-31-4.77
Q3 '242024-09-30-4.54
Q2 '242024-06-30-4.37
Q1 '242024-03-31-5.08
Q4 '232023-12-31-3.55
Q3 '232023-09-30-9.51
Q1 '222022-03-31-0.54
Q4 '212021-12-31-0.48
Q3 '212021-09-30-0.18
Q2 '212021-06-30-0.13
Q1 '212021-03-31-0.11
Q4 '202020-12-31-0.19
Q3 '202020-09-30-0.24
Q2 '202020-06-30-0.24